EDGAR Filing Documents for 0001104659-15-048163

Form 8-K - Current report:

SEC Accession No. 0001104659-15-048163

Filing Date

2015-06-29

Accepted

2015-06-29 06:01:17

Documents

Period of Report

2015-06-26

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-14669_18k.htm	8-K	83974
2	EX-3.1	a15-14669_1ex3d1.htm	EX-3.1	125533
3	EX-10.1	a15-14669_1ex10d1.htm	EX-10.1	149860
4	EX-10.2	a15-14669_1ex10d2.htm	EX-10.2	37870
5	EX-10.3	a15-14669_1ex10d3.htm	EX-10.3	49764
6	EX-10.4	a15-14669_1ex10d4.htm	EX-10.4	49133
7	EX-99.1	a15-14669_1ex99d1.htm	EX-99.1	7616
	Complete submission text file	0001104659-15-048163.txt		505233

Mailing Address 1040 SPRING ST SILVER SPRING MD 20910

Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292

UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)